Mats Lindblad

10PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursToxicology (incl. clinical toxicology)Human biophysics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 24, 2026
Incidence of lymph node metastases in pT1 chemo- and radiotherapy-naïve esophageal and gastric cancer in the Nordic countries: a retrospective multinational cohort analysis.

|Aug 26, 2026
Association of multidisciplinary team meetings and survival in gastric cancer patients: nationwide cohort study.

|May 14, 2026
Health-related quality of life comparing standard and prolonged time-to-surgery after neoadjuvant chemoradiotherapy for esophageal cancer: results from the multicenter, randomized, controlled NeoRes II trial.

|Apr 08, 2025
Omental preservation versus omentectomy in curative-intent gastrectomy for gastric cancer: Swedish population-based cohort study.

Biying Huang, Chih-Han Kung, Andrianos Tsekrekos

|Dec 10, 2024
Inter-rater variability in multidisciplinary team meetings of oesophageal and gastro-oesophageal junction cancer on staging, resectability and treatment recommendation: national retrospective multicentre study.

Christine Jestin Hannan, Solange León Risso, Mats Lindblad

|Apr 26, 2023
Antipsychotic drugs and risk of acute pancreatitis: A nationwide case-control study.

Omid Sadr-Azodi, Rickard Ljung, Mats Lindblad

Pageof 2

Frequent Collaborators

4 joint publications

Fredrik Klevebro

3 joint publications

Gustav Linder

3 joint publications

David Edholm

3 joint publications

Jakob Hedberg